← All Sponsors
SPONSOR

University of Rochester

Total Trials
9
Recruiting
9
Phases
Phase 4, Phase 3

University of Rochester is a clinical research sponsor with 9 registered studies on ClinicalTrials.gov, of which 9 are actively recruiting participants. Research covers conditions including Duchenne Muscular Dystrophy (DMD), Myotonic Dystrophy Type 1, Congenital DM1, Juvenile DM1.

The trial portfolio spans Phase 4, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University of Rochester

How many clinical trials has University of Rochester sponsored?
ClinicalMetric currently tracks 9 clinical trials sponsored by University of Rochester, of which 9 are actively recruiting participants. These trials cover conditions including Duchenne Muscular Dystrophy (DMD), Myotonic Dystrophy Type 1, Congenital DM1. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Rochester research focus on?
University of Rochester clinical trials span Duchenne Muscular Dystrophy (DMD), Myotonic Dystrophy Type 1, Congenital DM1, Juvenile DM1, Childhood DM1, and additional conditions. The research pipeline includes Phase 4, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Rochester clinical trial?
To participate in a University of Rochester trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Rochester trials with current recruitment status updated daily.

Clinical Trials by University of Rochester

NCT07092540
Recruiting

The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy (DMD)
NCT07630389
Recruiting

Remote Assessments and Genetic Determinants of Congenital and Childhood Myotonic Dystrophy

Myotonic Dystrophy Type 1
NCT05034432 Phase 4
Recruiting

The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients

Arrythmia
NCT07561034
Recruiting

The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease

Pulmonary Hypertension
NCT05960461
Recruiting

Families Moving Forward (FMF) Connect Pro for Mental Health Providers

Fetal Alcohol Spectrum Disorders
NCT06543173
Recruiting

Primary Preventive Ventricular Tachycardia Ablation In High-Risk Patients Who Receive A Prophylactic Implantable Cardioverter Defibrillator

Heart Failure
NCT05006482 Phase 3
Recruiting

Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial

Lymphoma
NCT07569445
Recruiting

Auditory EEG and Behavioral Assessments in Individuals With Rett Syndrome

Rett Syndrome
NCT04805528
Recruiting

Study of Non-invasive Acupuncture-like Transcutaneous Electrical Nerve Stimulation (Altens) to Help Alleviate Xerostomia After Radiation Therapy for Cancers of the Head and Neck

Head and Neck Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology